PHC GROUPPHC Holdings Corporation

  • About Us
  • Group Companies
  • Products & Services
  • Sustainability
  • Investor Relations
  • Newsroom

About Us

Corporate Overview History Mission Vision Values Value Creation Plan Leadership

Group Companies

Ascensia LSI Medience Wemex Epredia PHCbi

Products & Services

Cancer Pathology Biologic & Cell Preservation Diagnostic Testing Patient Record & Billing Software Diabetes Management Medical Device & Drug Delivery

Sustainability

Sustainability
  • CEO Message
  • Materiality
  • Corporate Integrity image
    Corporate Integrity
  • People Insights image
    People Insights
  • Environmental Sustainability image
    Environmental Sustainability
  • Social Responsibility image
    Social Responsibility

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

  • Corporate Governance
  • IR Basic Policy

IR LIBRARY

  • Financial Results
  • Presentation Materials
  • IR Materials
  • Mid-term Plan
  • Our Group Introduction

STOCK INFORMATION

  • Stock Overview
  • General Meeting of Shareholders
  • Stock Quotations
IR News Financial Highlights IR Calendar Contact IR Disclaimer

Newsroom

NEWSROOM

NEWS

  • PHC Holdings Corporation
  • PHC Group Companies
CareersContact
JP

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • PHC Corporation
  • LSI Medience Corporation
  • Wemex Corporation
  • Epredia Holdings Ltd.
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • PHC Corporation
  • LSI Medience Corporation
  • Wemex Corporation
  • Epredia Holdings Ltd.
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation
CareersContactJP
Newsroom > 2023 > PHC Holdings Corporation Sells All Shares of Its Associate, Lunaphore Technologies SA

News


2023

NewsJune 23, 2023

PHC Holdings Corporation Sells All Shares of Its Associate, Lunaphore Technologies SA

PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President, Representative Director and CEO: Shoji Miyazaki, hereafter PHCHD) announces that it has concluded a share transfer agreement on sales of all stock in Lunaphore Technologies SA (hereafter Lunaphore) to Bio-Techne Corporation. Lunaphore will no longer be a PHCHD associate upon this transfer.

Lunaphore is a life sciences company located in Switzerland. It offers next-generation products to support cancer research, and is developing ultra-fast automated tissue staining instruments for rapid immunohistochemical staining (IHC). PHCHD initially invested in the company in February 2020, followed by an additional investment in December 2022. The agreement of transferring 100% stock of Lunaphore was offered by Bio-Techne Corporation. PHCHD will continue to explore potential collaborations with Lunaphore, as well as expand its IHC solutions business through its own initiatives.

With this sale, PHCHD expects to primarily record a gain related to the stock sales in an associate in the second quarter of the fiscal year ending March 31, 2024. There will be no change in the previously announced forecast for the year.

About PHC Holdings Corporation

PHC Holdings Corporation (TSE 6523) is a global healthcare company with a mission of contributing to the health of society through healthcare solutions that have a positive impact and improve the lives of people. Its subsidiaries include PHC Corporation, Ascensia Diabetes Care Holdings AG, Epredia Holdings Ltd., Wemex Corporation, and LSI Medience Corporation. Together, these companies develop, manufacture, sell and service solutions across diabetes management, healthcare solutions, diagnostics and life sciences. The consolidated net sales in FY2022 were JPY 356.4 billion with global distribution of products and services in more than 125 countries and regions. Together, PHC Holdings Corporation and its subsidiaries make up PHC Group.
URL: www.phchd.com

Media contact

PHC Holdings Corporation
Corporate Communications Group
+81-3-6778-5311 E-mail:phc-pr@gg.phchd.com

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
Terms of UsePrivacy PolicyFacebookLinkedIn © PHC Holdings Corporation All rights reserved.